Cardiac drugs: Adjusting their use in aging patients

J. B. Schwartz, D. R. Abernethy

Research output: Contribution to journalReview article

Abstract

Reduced drug metabolism, both renal and hepatic, occurs with aging. Algorithms for dose adjustments of renally excreted drugs are available, but dose adjustments must be empiric for drugs which undergo hepatic metabolism. Decreased drug clearance in combination with potentially increased sensitivity to durgs in the elderly means that, as a general rule, drug dosages should be reduced as the age of the patient increases. The frequent need for multi-drug therapy may also lead to adverse effectts in the elderly compared with younger cardiac patients. Managing the geriatric patient requires careful drug monitoring and a heightened awareness of the potential for adverse drug effects.

Original languageEnglish (US)
Pages (from-to)31-34+37
JournalGeriatrics
Volume42
Issue number8
StatePublished - Jan 1 1987

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Fingerprint Dive into the research topics of 'Cardiac drugs: Adjusting their use in aging patients'. Together they form a unique fingerprint.

  • Cite this

    Schwartz, J. B., & Abernethy, D. R. (1987). Cardiac drugs: Adjusting their use in aging patients. Geriatrics, 42(8), 31-34+37.